5324062025-07-012025-09-305324062025-09-305324062025-03-315324062025-04-012025-09-305324062025-07-012025-09-30in-capmkt:OtherExpenses1Member5324062025-04-012025-09-30in-capmkt:OtherExpenses1Member5324062025-09-30OtherNoncurrentFinancialAssetsDomain15324062025-09-30OtherCurrentFinancialAssetsDomain15324062025-09-30OtherCurrentAssetsDomain15324062025-09-30OtherCurrentLiabilitiesDomain15324062025-07-012025-09-30in-capmkt:ReportableSegments1Member5324062025-07-012025-09-30in-capmkt:ReportableSegments2Member5324062025-04-012025-09-30in-capmkt:ReportableSegments1Member5324062025-04-012025-09-30in-capmkt:ReportableSegments2Member5324062025-07-012025-09-30in-capmkt:ReportableSegments1Member5324062025-07-012025-09-30in-capmkt:ReportableSegments2Member5324062025-04-012025-09-30in-capmkt:ReportableSegments1Member5324062025-04-012025-09-30in-capmkt:ReportableSegments2Member5324062025-07-012025-09-30in-capmkt:ReportableSegments1Member5324062025-09-30in-capmkt:ReportableSegments1Member5324062025-07-012025-09-30in-capmkt:ReportableSegments2Member5324062025-09-30in-capmkt:ReportableSegments2Member5324062025-07-012025-09-30in-capmkt:ReportableSegments1Member5324062025-09-30in-capmkt:ReportableSegments1Member5324062025-07-012025-09-30in-capmkt:ReportableSegments2Member5324062025-09-30in-capmkt:ReportableSegments2Memberiso4217:INRiso4217:INRxbrli:shares532406AVANTELNOTLISTEDINE005B01027AVANTEL LIMITEDMain BoardEquity2025-04-012026-03-312025-10-182025-10-10INRLakhsQuarterlySecond quarterMulti segment2025-10-1809:30:002025-10-1810:30:00trueCash Flow IndirectNot applicable2025-07-012025-09-30UnauditedConsolidated55418300090960005632790002056160000-4917300012538000012556000475610001591870005011270006215200006215200019489000019489000042663000000042663000042663000000052994500020.150.15000.150.151. The financial results of the company have been prepared in accordance with Indian Accouting Standards (Ind AS) notified under the companies (Indian Accouting standards) Rules, 2015 as amended by the companies (Indian Accouting standards) (Amendment) rules,2016. <br /> 2. Since the principal customer of the company is an organisation that is controlled by the Government of India, the company has been assured of its Receivables and has not made any provision for loss allowance in the past and as on date. Hence the company has concluded that no provision for loss allowance needs to be made as on September 30, 2025. The company will reassess the model periodically and make the necessary adjustments for loss allowance if any, on case to case basis if required. <br /> 3. The Consolidated financial results are reviewed by the Statutory Auditors of the Company as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirement) Regulations, 2015. <br /> 4. During the quarter, the Company has allotted 7,600 equity shares of face value Rs.2 each to eligible employees upon exercise of options vested under the Avantel Employees Stock Option Plan 2023. <br /> 5. Employee benefit Expenses include Rs. 177.57 Lakhs on account of ESOP, 2023 for the quarter ending September 30, 2025 and Rs. 324.97 Lakhs for the half year ending Septmber 30, 2025. <br /> 6. The aforementioned results are reviewed by the Audit Committee of the Board and subsequently taken on record by the board of directors at its meeting held on October18, 2025. <br /> 7. Figures for the previous year/period have been regrouped / reclassified where ever necessary to confirm to the current year's / period's presentation. <br /> 8. The results for the quarter and half-year ended September 30, 2025 are also available on the BSE Limited and National Stock Exchange of India Limited website and on the Company's website.2025-04-012025-09-30UnauditedConsolidated1073310000954700010828570002884620000746690002263180002056900091528000266057000967603000115254000011525400040243000040243000075011000000075011000075011000000052994500020.940.93000.940.93Other Expenses159187000Other Expenses26605700013009750001853270000000000002549700025497000451100015163100005522100000104331900038043000457587000060100001544959000303200027250300023727040000038890140005299450002706456000323640100003236401000000000500100005001000306900000904460001500300010544900041234900056466000129980000488170000647612000006526130003889014000Other non-current financial assets25497000Other current financial assets6010000Other current assets272503000Other current liabilities56466000Communications and signal processing products560336000Health Care2943000Communications and signal processing products1079152000Health Care37050005632790001082857000005632790001082857000Communications and signal processing products81191000Health Care-19039000Communications and signal processing products148263000Health Care-3300900062152000115254000000062152000115254000Communications and signal processing products3657859000Health Care231155000388901400003889014000Communications and signal processing products638794000Health Care1381900065261300006526130002056900052314000-330929000017500000107700006393000002705400009152800000-4800000-45440000000000036190000239360000-9696700018287000-624000002993000014670000000000000289835000263000000000000000000062400000-535872000-82482000000809804000000002158070001200000006328000529920001798800000828303000181530000181530001988900038042000000000